Timms E, Wakeham A, Paige CJ, Hartmann KU, Veillette A, Davidson
D, Mak TW (1992). Profound block in thymocyte development in mice
lacking p56lck. Nature 357: 161-164.
Moriwaki M, Itoh N, Miyagawa J, Yamamoto K, Imagawa A, Yamagata
K, Iwahashi H, Nakajima H, Namba M, Nagata S, Hanafusa T,
Matsuzawa Y (1999). Fas and Fas ligand expression in inflamed
islets in pancreas sections of patients with recent-onset Type I
diabetes mellitus. Diabetologia 42: 1332-1340.
Muir P, van Loon AM (1997). Enterovirus infections of the central
nervous system. Intervirol. 40: 153-166.
Nicholson DW, Thornberry NA (1997). Caspases: killer proteases.
Trends Biochem. Sci. 22: 299-306.
Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda
Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee
M (2000). Normalizing mitochondrial superoxide production blocks
three pathways of hyperglycaemic damage. Nature 404: 787-790.
Oda T, Akaike T, Hamamoto T, Suzuki F, Hirano T, Maeda H (1989).
Oxygen radicals in influenza-induced pathogenesis and treatment
with pyran polymer-conjugated SOD. Science 244: 974-976.
Ohba M, Shibanuma M, Kuroki T, Nose K (1994). Production of
hydrogen peroxide by transforming growth factor-beta 1 and its
involvement in induction of egr-1 in mouse osteoblastic cells. J. Cell
Biol. 126: 1079-1088.
Op De Beeck A, Caillet-Fauquet P (1997). Viruses and the cell cycle.
Prog. Cell Cycle Res. 3: 1-19.
Opavsky MA, Martino T, Rabinovitch M, Penninger J, Richardson C,
Petric M, Trinidad C, Butcher, L, Chan J, Liu PP (2002). Enhanced
ERK-1/2 activation in mice susceptible to coxsackievirus- induced
myocarditis. J. Clin. Invest. 109: 1561-1569.
Padaiga Z, Tuomilehto J, Karvonen M, Podar T, Brigis G, Urbonaite B,
Kohtamaki K, Lounamaa R, Tuomilehto-Wolf E, Reunanen A (1997).
Incidence trends in childhood onset IDDM in four countries around
the Baltic sea during 1983-1992. Diabetologia 40: 187-192.
Perl A, Gergely P Jr Puskas F, Banki K (2002). Metabolic switches of T-
cell activation and apoptosis. Antioxid Redox Signal. 4: 427-443.
Peterhans E, Grob M, Burge T, Zanoni R (1987). Virus-induced
formation of reactive oxygenintermediates in phagocytic cells. Free
Radic. Res. Commun. 3: 39-46.
Petronilli V, Costantini P, Scorrano L, Colonna R, Passamonti S,
Bernardi P (1994). The voltage sensor of the mitochondrial
permeability transition pore is tuned by the oxidationreduction state of
vicinal thiols. Increase of the gating potential by oxidants and its
reversal by reducing agents. J. Biol. Chem. 269: 16638-16642.
Pileggi A, Molano RD, Berney T, Cattan P, Vizzardelli C, Oliver R,
Fraker C, Ricordi C, Pastori RL, Bach FH, Inverardi L (2001). Heme
oxygenase-1 induction in islet cells results in protection from
apoptosis and improved in vivo function after transplantation.
Diabetes 50: 1983-1991.
Pinkoski MJ, Waterhouse NJ, Heibein JA, Wolf BB, Kuwana T,
Goldstein JC, Newmeyer DD, Bleackley RC, Green DR (2001).
Granzyme B-mediated apoptosis proceeds predominantly through a
Bcl-2-inhibitable mitochondrial pathway. J. Biol. Chem. 276: 12060-
12067.
Pipeleers D, Hoorens A, Marichal-Pipeleers M, Van de Casteele M,
Bouwens L, Ling Z (2001). Role of pancreatic beta-cells in the
process of beta-cell death. Diabetes 50(1): S52-57.
Platanias LC, Uddin S, Domanski P, Colamonici OR (1996). Differences
in signaling between IFNs and : IFN selectively induces the
interaction of the and L subunits of the Type I IFNR. J. Biol. Chem.
271: 23630–23633.
Pociot F, McDermott MF (2002). Genetics of type 1 diabetes mellitus.
Genes Immun 3: 235-249.
Polla BS, Jacquier-Sarlin MR, Kantengwa S, Mariethoz E, Hennet T,
Russo-Marie F, Cossarizza A (1996). TNF alpha alters mitochondrial
membrane potential in L929 but not in TNF alpha-resistant L929.12
cells: relationship with the expression of stress proteins, annexin 1
and superoxide dismutase activity. Free Radic. Res. 25: 125-131.
Rabinovitch A, Suarez-Pinzon WL, Strynadka K, Lakey JR, Rajotte RV
(1996b). Human pancreatic islet beta-cell destruction by cytokines
involves oxygen free radicals and aldehyde production. J. Clin.
Endocrinol. Metab. 81: 3197-3202.
Rabinovitch A, Suarez-Pinzon WL (1998). Cytokines and their roles in
Sharma et al. 057
pancreatic islet beta-cell destruction and insulin-dependent diabetes
mellitus. Biochem. Pharmacol. 55: 1139-1149.
Racaniello VR (2001). Picornaviridae: the viruses and their replication.
In: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman
B, Straus SE (eds.) Fields Virol., 4th ed, Lippincott Williams and
Wilkins,Philadelphia, USA. pp. 665-672.
Ramsingh AI (1997b). Coxcakieviruses and pancreatitis. Front. Biosci.
2: 53-62.
Ribeiro MM, Klein D, Pileggi A, Molano RD, Fraker C, Ricordi C.
Inverardi L, Pastori RL (2003). Hemeoxygenase-1 fused to a TAT
peptide transduces and protects pancreatic beta-cells. Biochem.
Biophys. Res. Commun.305: 876-881.
Robertson RP (2004). Chronic oxidative stress as a central mechanism
for glucose toxicity in pancreatic islet beta cells in diabetes. J. Biol.
Chem. 279: 42351-42354.
Robertson RP, Harmon J, Tran PO, Tanaka Y, Takahashi H (2003).
Glucose toxicity in pancreatic islets beta cells: type-2 diabetes, good
radicals gone bad and the glutathione connection. Diabetes 52: 581-
587.
Rodriguez J, Lazebnik Y (1999). Caspase-9 and APAF-1 form an
activeholoenzyme. Genes Dev. 13: 3179-3184.
Roep BO, Hiemstra HS, Schloot NC, De Vries RR, Chaudhuri A, Behan
PO, Drijfhout JW (2002). Molecular mimicry in type 1 diabetes:
immune cross-reactivity between islet autoantigen and human
cytomegalovirus but not Coxsackie virus. Ann. NY Acad. Sci. 958:
163-165.
Roivainen M, Piirainen L, Hovi T, Virtanen I, Riikonen T, Heino J,
Hyypia T (1994). Entry of coxsackievirus A9 into host cells: specific
interactions with alpha v beta 3 integrin, the vitronectin receptor.
Virology 203: 357-365.
Roivainen M, Ylipaasto P, Savolainen C, Galama J, Hovi T, Otonkoski T
(2002). Functional impairment and killing of human beta cells by
enteroviruses: the capacity is shared by a wide range of serotypes,
but the extent is a characteristic of individual virus strains.
Diabetologia 45: 693-702.
Romero-Alvira D, Roche E (1998). The keys of oxidative stress in
acquired immune deficiency syndrome apoptosis. Med. Hypotheses
51: 169-173.
Ronco LV, Karpova AY, Vidal M, Howley PM (1998). Human
papillomavirus 16 E6 oncoprotein binds to interferon regulatory
factor-3 and inhibits its transcriptional activity. Genes Dev. 12: 2061-
2072.
Rotbart HA (2002). Treatment of picornavirus infections. Antiviral Res.
53: 83-98.
Saitoh M, Nishitoh H, Fujii M, Takeda K, Tobiume K, Sawada Y,
Kawabata M, Miyazono K, Ichijo H (1998). Mammalian thioredoxin is
a direct inhibitor of apoptosis signal regulating kinase (ASK) 1. EMBO
J. 17: 2596-2606.
Samali A, Nordgren H, Zhivotovsky B, Peterson E, Orrenius S (1999). A
comparative study of apoptosis and necrosis in HepG2 cells: oxidant-
induced caspase inactivation leads to necrosis. Biochem. Biophys.
Res. Commun. 255: 6-11.
Santini SA, Marra G, Giardina B, Cotroneo P, Mordente A, Martorana
GE, Manto A, Ghirlanda G (1997). Defective plasma antioxidant
defenses and enhanced susceptibility to lipid peroxidation in
uncomplicated IDDM. Diabetes 46: 1853-1858.
Santos CX, Anjos EI, Augusto O (1999). Uric acid oxidation by
peroxynitrite: multiple reactions, free radical formation, and
amplification of lipid oxidation. Arch. Biochem. Biophys. 372: 285-
294.
Sawada M, Nakashima S, Kiyono T, Nakagawa M, Yamada J,
Yamakawa H, Banno Y, Shinoda J, Nishimura Y, Nozawa Y, Sakai N
(2001). Regulates ceramide formation by neutral sphingomyelinase
through reactive oxygen species in human glioma cells. Oncogene
20: 1368-1378.
Schloot NC, Willemen SJ, Duinkerken G, Drijfhout JW, de Vries RR,
Roep BO (2001). Molecular mimicry in type 1 diabetes mellitus
revisited: T-cell clones to GAD65 peptides with sequence homology
to Coxsackie or proinsulin peptides do not crossreact with
homologous counterpart. Hum. Immunol. 62: 299-309.
Schranz DB, Lernmark A (1998). Immunology in diabetes: an update.
Diabetes Metab. Rev. 14: 3-29.